News

US FDA approves Jazz Pharmaceuticals’ Modeyso to treat recurrent H3 K27M-mutant diffuse midline glioma: Dublin Friday, August 8, 2025, 11:00 Hrs [IST] Jazz Pharmaceuticals plc, ...
The FDA has granted accelerated approval to Modeyso (dordaviprone) for the treatment of diffuse midline glioma harboring an ...
The US Food and Drug Administration (FDA) has given accelerated approval to Jazz Pharmaceuticals for Modeyso (dordaviprone) ...
Three young friends of Maddie O’Hare Schmidt held a lemonade stand on Thursday to raise funds for Magic for Maddie, a ...
Glioma is the most common type of brain cancer in children and younger adults, originating in glial cells and categorized by ...
Modeyso is the first and only approved treatment for recurrent H3 K27M-mutant diffuse midline glioma in patients aged one ...
The 'Walking Dead' actress died on Aug. 2 at age 33 after being diagnosed with glioma of the central nervous system ...
Kelley Mack was said to be suffering from Diffuse midline glioma (DMG), which is a rare and aggressive brain tumor, which ...